Speaker Profile

Ph.D., Senior Vice President, Products and Services R&D, Genomic Health
Biography

Ellen Beasley has over 20 years of product development and program management experience in biotechnology and genomics sciences. She brings a record of successful integration and application of bioinformatics, genetics and genomics platforms to advance and accelerate life sciences instrument, diagnostics and therapeutics product discovery and development. Ellen started her career in human genomics at the Stanford Human Genome Center and lead the team developing physical maps of the human genome. She then moved to Celera Genomics and participated in the genome sequencing and gene discovery efforts for the human genome. After the completion of the human genome, Ellen managed various discovery efforts to apply the human genome, including drug target discovery efforts, investigation of the genetic basis of autoimmune disease and companion diagnostic partnership development. Ellen then moved to Perlegen Sciences where she was Senior Vice President of R&D Operations, managing companion diagnostic programs and building the CLIA lab for commercialization of a breast cancer risk assay. In 2009, Ellen joined Life Technologies and was Vice President of Biological Information Systems, leading a team to develop methods and software tools to exploit the data from next generation sequencers. Since joining Genomic Health in 2013, Ellen has focused on the application of next generation technologies, including sequencing and liquid-based biopsy, to discover and develop Genomic Health’s next generation of products to serve patients living with cancer.

Clinical Dx Showase: Genomic Health
Genomic Health is dedicated to securing reimbursement to ensure cancer patients around the world have access to our clinically actionable Oncotype DX tests.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

You have Successfully Subscribed!